Find a TenderAwarded without competitionContract award notice
Published 29 May 2026, 23:23 BST

Official UK procurement notice

KMMH Portable Magnetic Resonance Imaging System (2026)

Official notice

Authority: Kent and Medway Mental Health NHS Trust (Central government)

Direct awardSME suitable
Awarded value£287,220published award · exc. VAT
Award in standstill 18 Jun 2026no call for competition
Award (standstill) to Xiel Limited

What is being bought

Published requirement description

Kent and Medway Mental Health NHS Trust (the “Trust”) is awarding a contract for the provision of a portable low-field (0.064 Tesla) magnetic resonance imaging (MRI) system. The contract will also include the provision of associated peripherals, together with training, support and maintenance services, for a period of five (5) years.

The MRI system will be utilised to support the acceleration and development of local, place-based neuroimaging research, particularly in relation to the assessment and diagnosis of dementia, where timely access to imaging is frequently a rate-limiting factor. The system will also be made available to support research into other mental health conditions, including initiatives aligned to the Kent Complex Psychosis Service and wider investigation into non-dementia mental illness affecting both older and younger adults.

A key objective of this programme is to facilitate the development of new artificial intelligence (AI) algorithms for the assessment of structural brain changes associated with dementia and cognitive decline. This is intended to reduce reliance on high-field MRI imaging within specialist centres and to avoid the associated restrictive clinical environments.

In order to support these research objectives, the Trust requires a system that meets the following essential criteria:

  • Approval for commercial sale in the United Kingdom (UKCA marking);
  • A compact and highly portable design, capable of passing through standard doorways and elevators and allowing ease of manoeuvrability within clinical environments;
  • A magnetic configuration that enables researchers to work safely in close proximity to participants during imaging procedures;
  • Operation via standard electrical power outlets;
  • Low power consumption to minimise ongoing operational costs;
  • An open design to reduce participant anxiety and improve patient experience; and
  • Operation via a portable, user-friendly wireless device (for example, a tablet).

The Trust considers that the direct award of this contract is justified pursuant to paragraph 6 of Schedule 5 to the Procurement Act 2023.

Accordingly, the Trust published a Transparency Notice (ref 2026/S 000-051128) on 29 May 2026 to inform the market of its intention to enter into the contract by way of direct award.

The dates included in this Award Notice are provided for indicative purposes only. The actual contract commencement date shall be determined by the date on which the Goods are delivered.

The lotProcurement structure

single lot · no lot value published
Lot #1AwardedSME

Procedure terms & legal framework

From the official record
Procedure method
Direct award
Legal basis
UKPGA · 2023/54 Procurement Act 2023
Notice status
Awarded without competition
Procurement threshold
Unspecified in notice
Regulatory regime
Standard
Commercial structure
Stand-alone contract (no framework)
Competition type
Direct award (no call for competition)
GPA / WTO covered
Unspecified in notice
Recurring procurement
Unspecified in notice
First published
29 May 2026, 23:23 BST
Last source update
18 Jun 2026, 17:21 BST
FTS notice number
2026/S 000-057774
Latest notice
Contract award notice (UK6)
Delivery area
South East (UKJ4)
Official registry OCID
ocds-h6vhtk-06a9b0 Find a Tender
Why no open competition
Single Suppliers Technical Reasons
Published justification

The Trust considers that the direct award of this contract is justified pursuant to paragraph 6 of Schedule 5 to the Procurement Act 2023., whereby the following conditions are met:

(a) due to an absence of competition for technical reasons, only a particular supplier can supply the goods, services or works required, and

(b) there are no reasonable alternatives to those goods, services or works.

Following the completion of appropriate market research, the Trust is satisfied that the required goods and associated services can only be supplied by a single economic operator, and that no reasonable alternatives or substitutes exist.

This conclusion is informed by the Trust’s core requirements for a portable, low-field MRI system that is optimally suited to support the acceleration and development of local, place-based neuroimaging clinical research. The essential characteristics of the required system include:

  • Approval for commercial sale in the United Kingdom (UKCA marking);
  • A compact and highly portable design, capable of passing through standard doorways and elevators and allowing ease of manoeuvrability within clinical environments;
  • A magnetic configuration that enables researchers to work safely in close proximity to participants during imaging procedures;
  • Operation via standard electrical power outlets;
  • Low power consumption to minimise ongoing operational costs;
  • An open design to reduce participant anxiety and improve patient experience; and
  • Operation via a portable, user-friendly wireless device (for example, a tablet).

The Trust considers that Xiel Ltd is the exclusive UK distributor of the Hyperfine Portable MR Imaging System and is therefore the only economic operator capable of supplying an existing solution that meets the above requirements.

Accordingly, Xiel Ltd is deemed to be the sole supplier able to support the Trust’s objectives for delivering local, place-based neuroimaging clinical research within the required timescales.

How it was run

Official notice
Submission deadline
—

Timeline

18 Jun 2026 → 29 Jun 2026 · 2 dates
  1. Notice published131 days ago
    18 Jun 2026, 17:21 BST
  2. Standstill ends120 days ago
    29 Jun 2026, 23:59 BST

Notice history

4 events · 3 releases on Find a Tender · since 29 May 2026
  1. Transparency notice published
    29 May 2026, 23:23 BST
    UK5
  2. Transparency notice published
    30 May 2026, 00:03 BST
    UK5
  3. Contract award notice published
    18 Jun 2026, 17:21 BST
    UK6
  4. Contract signature expected
    1 Jul 2026, 23:59 BST
    scheduled

Commercial outcome & contract awards

Published awards, contracts and bid statistics, not a forecast
Awards 1
Awarded value £287,2201 award exc. VAT
Awarded toValueDateStatus
Xiel LimitedSME1 Sept 2026 – 31 Aug 2031Options: Lifetime support services, including software updates and hardware servicing, are optional, and the Trust may purchase these products individually at at any time during the Contract Term. · Amended: Paragraph 5(a)(b) of Schedule 5 to the Procurement Act 2023 was erroneously cited in the direct award justification. This has been updated to correctly reference paragraph 6(a)(b) of Schedule 5.£287,22018 Jun 2026standstill to 29 Jun 2026Standstill

Contracting authority & participating public bodies

Kent and Medway Mental Health NHS Trust

Contracting authorityPublic authority - central government GB-PPON: PNZR-1968-PDPD Priority House, Hermitage Lane, Maidstone, South East, ME16 9PHContact email

Bidders & participating suppliers

1 commercial party on the notice
  • Xiel LimitedAwarded supplierGB-COH: 11875702 26-27 Capitol Park Capitol Way, Colindale, London, London, NW9 0EQContact email

Official documents & specifications (3)

Official links; attachments are not copied

Notices published for this procedure

  • Contract award notice awardContract award noticeUK6Contract award notice on Find a Tender
  • Transparency notice awardTransparency noticeUK5Transparency notice on Find a Tender
  • Transparency notice awardTransparency noticeUK5Transparency notice on Find a Tender